Edward J. Sitar

Ed Sitar is currently serving as the Chief Financial Officer at Variantyx, a precision medicine company. Prior to this, Ed held various financial leadership roles at companies such as Timber Pharmaceuticals, 9 Meters Biopharma, CareDox, Ammon Analytical Laboratory, Cancer Genetics, Healthagen, ActiveHealth Management, Cadent Holdings, and Bioscrip. Ed graduated from the University of Scranton with a Bachelor of Science in Accounting and has a strong background in financial management and strategic transactions.